Bazemore Todd

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$115,330.78
Insider Sells Quantity
9
Insider Sells Sum
$136,356.22

Insider Activity of Bazemore Todd

According to the SEC Form 4 filings, Bazemore Todd, being in a position of

  1. SEE REMARKS at Kala Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 8151 share for $44,318,
    over all time since 2020-03-16, has bought 20084 shares for $115,331, and sold 49337 shares for $136,356.

The largest purchase of all time was on 2020-03-16 and amounted to 20000 shares of Kala Pharmaceuticals, Inc. for $115,000.

The largest sale of all time was on 2021-10-26 and amounted to 25088 shares of Kala Pharmaceuticals, Inc. for $45,158.

Biography of Bazemore Todd

No biography is available at this moment.

2024-06-26SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
4,653
0.1706%
$4.75$22,102+28.91%
2024-05-31SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
2,093
0.0673%
$6.09$12,746-11.46%
2024-01-04SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
1,405
0.0502%
$6.74$9,470-2.14%
2023-01-04SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
62
0.002%
$28.54$1,769-66.29%
2022-10-26SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
214
0.0138%
$6.51$1,393+128.67%
2022-06-27SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
3,092
0.0043%
$0.37$1,144-16.76%
2022-01-04SaleKala Pharmaceuticals, Inc.
KALA
SEE REMARKS
6,908
0.0096%
$1.30$8,980-72.68%
2021-10-26SaleKala Pharmaceuticals, Inc.
KALA
CHIEF OPERATING OFFICER
25,088
0.0386%
$1.80$45,158-61.94%
2021-06-28SaleKala Pharmaceuticals, Inc.
KALA
CHIEF OPERATING OFFICER
5,822
0.0094%
$5.77$33,593-72.03%
2020-10-22PurchaseKala Pharmaceuticals, Inc.
KALA
Chief Operating Officer
80
<0.0001%
$3.80$304-14.36%
2020-06-05PurchaseKala Pharmaceuticals, Inc.
KALA
Chief Operating Officer
4
<0.0001%
$6.70$27-43.41%
2020-03-16PurchaseKala Pharmaceuticals, Inc.
KALA
Chief Operating Officer
20,000
0.046%
$5.75$115,000+41.03%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.